OPA1 and autosomal dominant optic atrophy: Patients with mutated OPA1 develop autosomal dominant optic atrophy (ADOA) and neutrophils from these patients have a reduced ability for extracellular DNA released and impaired ability for pathogen killing due to impaired complex I activity, and limited NAD+ for glycolytic ATP production (113).